In patients with nickel hypersensitivity, there is increased risk for device syndrome within the first 90 days following patent foramen ovale closure.

The Amplatzer occluder (AGA Medical Corporation, Plymouth, MN), the only such device approved by the US Food and Drug Administration, is made of nitinol (approximately 45% nickel) and releases ...